Anavex Life Sciences Corp (AVXL)

[seventhwave]

Rare Pediatric Disease, Priority Review Voucher from FDA

I wonder if AVXL is taking any steps to secure one. They are very valuable and can be 'traded', a recent example being Sarepta selling theirs for $125 mil. (see 2nd link) Would solve ALL our funding problems.

https://www.fda.gov/forindustry/developingproductsforrarediseasesconditions/rarepediatricdiseasepriorityvoucherprogram/default.htm


http://www.raps.org/Regulatory-Focus/News/2015/07/02/21722/Regulatory-Explainer-Everything-You-Need-to-Know-About-FDA%E2%80%99s-Priority-Review-Vouchers/